Kanokphorn Thonglert,M.D.
ABOUT DR. KANOKPHORN THONGLERT
Dr. Kanokphorn Thonglert graduated from the Faculty of Medicine at Chulalongkorn University, Bangkok, and completed her residency in radiation oncology at the same institution in 2020. She further advanced her expertise in proton therapy and gastrointestinal cancer as a visiting scholar at the University of Washington in Seattle, USA, from 2023 to 2024. Additionally, she was a visiting scientist at the proton center at the Paul Scherrer Institut (PSI) in Switzerland for one month between March and April 2024.
Dr. Thonglert specializes in proton therapy and advanced radiation treatments, including IMRT/VMAT, stereotactic radiotherapy (SRS/SRT), MRI-based brachytherapy, and adaptive radiotherapy. Her primary focus areas include hepatobiliary cancer, colorectal cancer, anal canal cancer, renal cancer, bladder cancer, prostate cancer, cervical cancer, and uterine cancer.
She is dedicated to offering personalized treatment options tailored to each patient’s specific needs and goals, ensuring that the care provided is both effective and compassionate.
- 2014 Doctor of Medicine (First Class Honor), Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
- 2020 Diploma of the Thai Board of Radiation Oncology Division of Therapeutic Radiation and Oncology, Department of Therapeutic Radiation and Oncology, King Chulalongkorn Memorial Hospital, Bangkok, Thailand
- 2023 Visiting Scholar in Proton Therapy and Gastrointestinal Service at Radiation Oncology Department, University of Washington School of Medicine, Seattle, Washington, USA
- 2024 Visiting Scientist at Proton Therapy Center, Paul Scherrer Institute, Switzerland
- 2020 Thai Board of Radiation Oncology
- 2020 Present Lecturer in Radiation Oncology, Division of Therapeutic Radiation Oncology, Department of Radiology, King Chulalongkorn Memorial Hospital, Bangkok, Thailand
- 2019 Poster presentation at ESTRO 2019, Milan, Italy. Combined chemoembolization and radiotherapy for hepatocellular carcinoma with portal vein thrombosis
- 2020 Best Practice Residence during residency training
- 2022-Present Member of Thai Society of Therapeutic Radiology and oncology
Write of book “Prostate Cancer after Radiotherapy, Chapter 10: Management of Recurrent Prostate Cancer after Radiotherapy” in Thai language, p. 193-225, Bangkok, Chulalongkorn, 2022
Write of book “Prostate Cancer after Radiotherapy, Chapter 12: Side Effect of Radiation Treatment in Prostate Cancer” in Thai language, p. 234-46, Bangkok, Chulalongkorn, 2022
Write of book “The Stories of Success, Chapter 15: The Role of External Beam Radiotherapy in Hepatocellular Carcinoma” in Thai language, p. 256-295, Bangkok, Print & More Company Limited, 2022
Write of book “The Stories of Success, Chapter 16: External Beam Radiotherapy Technique and Fractionation Regimen for Hepatocellular Carcinoma” in Thai language, p. 296-316, Bangkok, Print & More Company Limited, 2022
Write of book “The Stories of Success, Chapter 17: radiation-induced liver disease; RILD” in Thai language, p. 317-328, Bangkok, Print & More Company Limited, 2022
Khorprasert C, Thonglert K, Alisanant P, Amornwichet N (2021) Advanced radiotherapy technique in hepatocellular carcinoma with portal vein thrombosis: Feasibility and clinical outcomes. PLoS ONE 16(9): e0257556. https://doi.org/10.1371/journal.pone.0257556
Thonglert K, Ditjarern P, Amornwichet N, Alisanant P, Khorprasert C. Retrospective Study of Salvage Dose-Escalated Intensity-Modulated Radiation Therapy in Radiotherapy-naïve, Non-metastatic, Castration-Resistant Prostate Cancer. J Thai Assn of Radiat Oncol [Internet]. 2022 Mar. 3 [cited 2022 May 22];28(1):R1-R15. Available from: https://he01.tci-thaijo.org/index.php/jtaro/article/view/252522
Thonglert K. The role of external beam radiotherapy in the treatment of hepatocellular carcinoma. J Thai Assn of Radiat Oncol [Internet]. 2022 Jun. 29 [cited 2022 Dec. 29];28(1):O1-O48. Available from: https://he01.tci-thaijo.org/index.php/jtaro/article/view/255675
Prayongrat A, Srimaneekarn N, Thonglert K, Khorprasert C, Amornwichet N, Alisanant P, et al. Machine learning-based normal tissue complication probability model for predicting albumin-bilirubin (ALBI) grade increase in hepatocellular carcinoma patients. Radiat Oncol. 2022;17(1):202.
Thonglert K, Chuong MD, Herrera R, Apisarnthanarax S. Advanced and emerging radiation therapy approaches for intrahepatic cholangiocarcinoma. Hepatoma Research. 2023; 9: 40. http://dx.doi.org/10.20517/2394-5079.2023.47
Treewatthanawong, K., Amornwichet, N., Alisanant, P., Khorprasert, C. (2019, Apr 26-30). Combined chemoembolization and radiotherapy for hepatocellular carcinoma with portal vein thrombosis. [Poster presentation], European Society for Radiotherapy and Oncology, Milan, Italy.
Thonglert, K. (2022, Feb 12-13). Hepatocellular Carcinoma [Conference Presentation] Refresher Course for Residents in Radiation Oncology, Bangkok, Thailand.
Thonglert, K. (2022, Mar 24-27). Adaptive Radiotherapy: Current Concept, Clinical Experience and Workflow [Conference Presentation] Thai Association Radiation Oncology (THASTRO) Annual Meeting, Bangkok, Thailand.
Watthanasathitarpha, G., Pattarajierapan, S., Thonglert, K., Amornwichet, N., Alisanant, P., Khorprasert, C., Khomvilai. S. (2022, Dec 1-3). Predictors of bleeding ulceration due to argon plasma coagulation in radiation proctitis [Conference session]. Korean Digestive Disease Week, Incheon, Korea.
Zaki, P., Thonglert, K., Bowen, SR., Grassberger, C., Tsai, J., Apisarnthanarax, S., Nyflot MJ. (2023, July 23-27). Patients with higher baseline liver status show less functional decline following radiotherapy: a functional imaging analysis [Poster Presentation], American Association of Physicists in Medicine, Houston, Taxus, USA
Thonglert, K., Tsai, J., Anderson, AC., Nyflot, M., Bowen, S., Grassberger, C., Zaki, P., He, Y., Johnson, G., Monsky, W., Apisarnthanarax, S. (2023, October 29). Safety and Efficacy of Proton Beam Therapy in High-Risk Hepatocellular Carcinoma Patients Previously Treated with Yttrium-90 Radioembolization [Conference session]. Particle Therapy Cooperative Group – North America, Seattle, WA, USA
Tsai, J., Thonglert, K., Anderson, AC., Nyflot, M., Bowen, S., Grassberger, C., Zaki, P., He, Y., Apisarnthanarax, S. (2023, October 29). Efficacy and toxicity of proton beam therapy re-irradiation for primary anorectal cancer patients with prior pelvic radiotherapy [Poster Presentation]. Particle Therapy Cooperative Group – North America, Seattle, WA, USA
Thonglert, K., Tsai, J., Anderson, AC., Nyflot, M., Bowen, S., Grassberger, C., Zaki, P., He, Y., Johnson, G., Monsky, W., Apisarnthanarax, S. (2024, Jan 18-20). Safety and Efficacy of External Beam Radiation in Hepatocellular Carcinoma Patients Previously Treated with Yttrium-90 Radioembolization [Poster Presentation]. ASCO Gastrointestinal Cancers Symposium, San Francisco, USA
Thonglert, K. (2024, April 27). Ethos: The Impact of Adaptive Radiotherapy (ART) Expanding the Pathway [Conference Presentation] Vietnam Oncology Summit, Can Tho, Vietnam
Yulun He, Kanokphorn Thonglert, Peter Zaki, Stephen Bowen, Clemens Grassberger, Smith
Apisarnthanarax, Matthew Nyflot (2024, July 21-25). Defining the Functional Liver Remnant for Radiotherapy: Assessment of Liver Function Using Longitudinal SPECT/CT Imaging [Poster Presentation]. American Association of Physicists in Medicine, Los Angeles, California, USA
Treewatthanawong K, Amornwichet N, AlisanantP, KhorprasertC. Combined chemoembolization and radiotherapy for hepatocellular carcinoma with portal vein thrombosis. (Abstract presentation in ESTRO 2019, Milan Italy)
Khorprasert C, Thonglert K, Alisanant P, Amornwichet N (2021) Advanced radiotherapy technique in hepatocellular carcinoma with portal vein thrombosis: Feasibility and clinical outcomes. PLoS ONE 16(9): e0257556. https://doi.org/10.1371/journal.pone.0257556
Thonglert K, Ditjarern P, Amornwichet N, Alisanant P, Khorprasert C. Retrospective Study of Salvage Dose-Escalated Intensity-Modulated Radiation Therapy in Radiotherapy-naïve, Non-metastatic, Castration-Resistant Prostate Cancer. J Thai Assn of Radiat Oncol [Internet]. 2022 Mar. 3 [cited 2022 May 22];28(1):R1-R15. Available from: https://he01.tci-thaijo.org/index.php/jtaro/article/view/252522
Thonglert K. The role of external beam radiotherapy in the treatment of hepatocellular carcinoma. J Thai Assn of Radiat Oncol [Internet]. 2022 Jun. 29 [cited 2022 Dec. 29];28(1):O1-O48. Available from: https://he01.tci-thaijo.org/index.php/jtaro/article/view/255675
Prayongrat A, Srimaneekarn N, Thonglert K, Khorprasert C, Amornwichet N, Alisanant P, et al. Machine learning-based normal tissue complication probability model for predicting albumin-bilirubin (ALBI) grade increase in hepatocellular carcinoma patients. Radiat Oncol. 2022;17(1):202.
กนกพร ทองเลิศ, “การรักษาผู้ป่วยที่มีโรคกำเริบหลังการรักษาด้วยรังสี” ใน การรักษามะเร็งต่อมลูกหมากด้วยรังสี, ชลเกียรติ ขอประเสริฐ บรรณาธิการ (กรุงเทพฯ: สำนักพิมพ์แห่งจุฬาลงกรณ์, 2565), หน้า 193-225.
2020 – Present Member of Thai Society of Therapeutic Radiology and Oncology
Journal of Thai Association of Radiation Oncology